Greg Brown

Greg Brown is the Chief Executive Officer of Memgen, Inc., a biotechnology company focused on cancer treatment through immune system harnessing. With a background as a transplantation immunologist and thoracic vascular surgeon, Greg has also co-founded HealthCare Royalty Partners and serves on several boards, including Aquestive Therapeutics, Inc. and Lisata Therapeutics, Inc. Educated at Yale, SUNY Upstate Medical Center, and Harvard Business School, Greg's career includes leadership roles in investment firms and extensive experience in biopharma financing and product evaluation.